Posts by Muana Minkoué
Atinary and Takeda collaborate to drive innovation in healthcare
Atinary Technologies, a Vaud based startup, announced a strategic collaboration with Takeda, Japanese largest pharmaceutical company. This partnership brings together the two company’s complementary expertise, paving the way for innovative AI solutions poised to transform pharmaceutical R&D and accelerate drug discovery. Through this collaboration, Takeda will leverage Atinary’s leading AI Self-Driving Labs technology,…
Read MoreInnovative materials to combat bacteria
A UNIGE team is developing new alloys with bactericidal properties to combat antibiotic-resistant germs. While crucial to biotechnology, bacteria can also cause severe disease, exacerbated by their increasing resistance to antibiotics. This duality between economic benefits and infectious risks underlines the importance of finding ways to control their development. A team at the…
Read MoreAlys Pharmaceuticals launches with $100 Million financing from Medicxi
Formed through the aggregation of six-asset centric Medicxi companies, including Aldena Therapeutics, Alys boasts a robust R&D pipeline of cutting-edge programmes and platforms targeting multiple dermatological indications. Co-founded by Medicxi and several world-leading dermatology and scientific experts, Alys is a Boston and Geneva-based cutting edge pure-play immuno-dermatology company. It combines the assets and…
Read MoreCHF 870 Million invested in Swiss medtech and biotech companies
In the midst of an unfavourable environment, the life sciences’ sector continues to attract investors in Switzerland according to the Swiss Venture Capital Report 2024. In 2023, the downturn on the global venture capital market reached Switzerland. Swiss startups received a total of CHF 2.6 Billion last year, 35% less than in 2022.…
Read MoreFONGIT Café+Croissant at Campus Biotech
The next FONGIT Café+Croissant is taking place on 26 June 2025 at Campus Biotech Geneva. This monthly event brings together the entire FONGIT team and leading entrepreneurs from the local life sciences innovation community. Come find out what’s been going on in the Geneva life sciences startup scene, hear from entrepreneurs themselves, and expand…
Read MoreFirst-in-Human implantation for Novostia’s heart valve
The Vaud-based startup, located at the Biopôle, successfully implanted its TRIFLO valve in a human. Novostia, a pioneering medical technology company, proudly announces a significant milestone in its mission to revolutionize cardiovascular care. Last December, the company has successfully implanted its groundbreaking TRIFLO Heart Valve in a human patient for the first time.…
Read MoreDebiopharm Innovation Fund invests in MedaSystems
MedaSystems secures additional funding from Debiopharm Innovation Fund to accelerate global access to pre-approval treatment. Medasystems, a pioneer in software to provide access to pre-approval medicine, announced funding from Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm, motivated by their vision of patient centric, data-enabled clinical research and enabling…
Read MoreCellestia secures a CHF 2 Million grant from Innosuisse
The Biopôle based startup was awarded an Innosuisse Grant to advance a groundbreaking Graft versus Host Disease prevention therapy. Cellestia Biotech AG (Cellestia) announced its selection for a CHF 2 million grant from the Swiss Innovation Agency, Innosuisse, as part of their Startup Innovation project to advance to clinical Proof of Concept, a…
Read MoreDIA Europe
DIA Europe 2026 is taking place from 24 to 26 March 2026 in Rotterdam From the environmental impact of pharmaceuticals and of the drug development lifecycle to sustainable partnerships and sustainable healthcare systems, DIA Europe 2026 will be the prime opportunity to discuss how collaboration and innovation can support sustainability in healthcare and each stakeholder’s role…
Read More